UK Manufacturing: The Onshoring Opportunity

A Structural Shift, Not a Passing Trend

The UK manufacturing sector is at a pivotal moment. Years of supply chain disruption — driven first by Brexit, then by the pandemic, and more recently by geopolitical tensions and rising freight costs — have fundamentally altered the calculus for where goods are produced. The result is a growing strategic imperative to bring manufacturing back to British soil.

According to Make UK's Q1 2026 Manufacturing Outlook, the sector is expected to return to growth of 0.9% in 2026 following a slight contraction in 2025. While the headline figures remain modest, the underlying dynamics reveal a far more significant structural opportunity: the reshoring of production capacity that had migrated overseas over decades of globalisation.

The Import Dependency Problem

The UK's over-reliance on imported goods has been exposed as a strategic vulnerability. In sectors like tissue and paper products, approximately 35% of domestic demand is met by imports, creating a capacity gap of roughly 700,000 tonnes per year. Similar dynamics exist across food processing, pharmaceuticals, construction materials, and consumer goods. Rising shipping costs, carbon border adjustments, and the complexities of post-Brexit customs have eroded the cost advantage that once made offshore manufacturing the default choice.

Make UK has highlighted that raising the UK's investment intensity from 17% to 22% of GDP — a 0.5% annual increase — could unlock £670 billion in additional public and private investment over the next decade, with manufacturers potentially benefiting from around £44 billion in extra capital. The opportunity is real, but it requires decisive action from both government and private capital.

Sectors Poised to Benefit

Not all sectors present equal opportunities for onshoring. The most compelling investment cases share common characteristics: large addressable domestic markets currently served by imports, high freight-to-value ratios that penalise long-distance shipping, regulatory or certification requirements that favour local production, and alignment with the UK's net-zero agenda. Key sectors include:

Tissue and Paper Products. The UK tissue market alone is valued at approximately £3 billion annually and is structurally undersupplied domestically. FSC-certified, UK-manufactured tissue carries inherent advantages in both ESG credentials and supply chain resilience — a thesis reflected in opportunities Bowie Capital is currently supporting.

Waste Processing and Circular Economy. Innovative recycling technologies for construction, demolition, and excavation waste represent a massive market opportunity driven by tightening environmental regulations and carbon reduction targets. Companies developing proprietary processing technology can capture significant value as the UK transitions toward a circular economy model.

Clean Energy and Infrastructure. The electrification of the economy and the rollout of smart grid infrastructure require substantial domestic manufacturing capacity — from battery components to smart meters. Government initiatives around the Industrial Strategy are beginning to unlock investment in these areas.

Advanced Manufacturing and Automation. A recent industry survey found that nearly two-thirds of UK manufacturers (65%) believe opportunities will outweigh risks in 2026, with many actively investing in automation and digital tools to improve efficiency. As employment costs rise, technology investment is becoming a strategic necessity rather than an option, creating opportunities for capital deployment in Industry 4.0 solutions.

The Investment Case

For investors, UK manufacturing onshoring presents a distinctive combination of domestic demand security, ESG alignment, and government policy support. The launch of the UK's Industrial Strategy has lifted confidence, with 63% of manufacturers saying it will increase their investment plans. Companies that can demonstrate contracted domestic revenue, phased capacity ramp-ups, and strong environmental credentials are well positioned to attract both equity and debt capital.

At Bowie Capital, we are actively supporting businesses that embody this onshoring thesis. Our mandate pipeline includes companies building new domestic manufacturing capacity across tissue production, waste recycling, and energy infrastructure — each addressing structural import dependencies while creating skilled employment and reducing supply chain emissions. We believe this convergence of commercial opportunity and national strategic interest will define some of the most compelling private market investments of the next decade.